Programme

** Programme is subject to change without prior notice
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
  • 09:00
  • 09:10
  • 09:20
  • 09:30
  • 09:40
  • 09:50
  • 10:00
  • 10:10
  • 10:20
  • 10:30
  • 10:40
  • 10:50
  • 11:00
  • 11:10
  • 11:20
  • 11:30
  • 11:40
  • 11:50
  • 12:00
  • 12:10
  • 12:20
  • 12:30
  • 12:40
  • 12:50
  • 13:00
  • 13:10
  • 13:20
  • 13:30
  • 13:40
  • 13:50
  • 14:00
  • 14:10
  • 14:20
  • 14:30
  • 14:40
  • 14:50
  • 15:00
  • 15:10
  • 15:20
  • 15:30
  • 15:40
  • 15:50
  • 16:00
  • 16:10
  • 16:20
  • 16:30
  • 16:40
  • 16:50
  • 17:00
  • 17:10
  • 17:20
  • 17:30
  • 17:40
  • 17:50
  • 18:00
  • 18:10
  • 18:20
  • 18:30
  • 18:40
Lecture Theatre 1A
Lecture Theatre 1B
Room 209
CRC: prevention is better than cure
Lecture Theatre 1A
09:00-10:30
09:00
Tailoring CRC screening in the young: latest recommendations
09:30
Novel non-invasive markers for CRC and adenoma detection
10:00
Chemoprevention of CRC: what should you tell your patient
Towards functional cure of HBV
Lecture Theatre 1B
09:00-10:30
09:00
Stopping antiviral to achieve functional cure
09:30
What can we get from functional cure of HBV?
10:00
The weapons in the pipeline to cure HBV
GUT-IDDF Young Investigator Award (1): Oral Presentation I
Room 209
09:00-10:30
09:00
GUT-IDDF Young Investigator Award (1): Oral Presentation I
COVID-19 has GUTS
Lecture Theatre 1A
11:00-12:30
11:00
Gut and COVID-19: evolving lessons
11:30
Do IBD drugs impact COVID-19 vaccine?
12:00
Gut microbiome modulation and COVID-19
Management of NAFLD
Lecture Theatre 1B
11:00-12:30
11:00
Are blood biomarkers ready for prime time?
11:30
Novel imaging tests of hepatic steatosis and fibrosis
12:00
Metabolic drug treatment for NASH
GUT-IDDF Young Investigator Award (2): Oral Presentation II
Room 209
11:00-12:30
11:00
GUT-IDDF Young Investigator Award (2): Oral Presentation II
Lunch Symposium (A)
Lecture Theatre 1A
13:20-14:20
13:20
Lunch Symposium (A)
Lunch Symposium (B)
Lecture Theatre 1B
13:20-14:20
13:20
Lunch Symposium (B)
Opening Ceremony & Keynote Lectures: Joseph Sung Distinguished Lecture & Dr S H Ho Memorial Lecture
Lecture Theatre 1A
14:20-15:40
14:20
Opening Ceremony
14:40
Joseph Sung Distinguished Lecture
15:10
Dr S H Ho Memorial Lecture
New kids on the block in IBD
Lecture Theatre 1A
16:10-17:40
16:10
New biologics and treatment targets in crohn’s disease
16:40
Anti-inflammatory diet and food additives
17:10
Choosing and positioning therapies for UC
State Key Lab Meeting (1): GI cancer immunotherapy-basic to translational research
Lecture Theatre 1B
16:10-17:40
16:10
Immunotherapy in NASH-HCC
16:40
m6A and immunotherapy in CRC
17:10
T cell mediated anti-tumor therapy
Asian Frontiers in GI Endoscopy (AFGIE) Symposium
Room 209
16:10-17:50
16:10
Challenges and coping strategies for advanced endoscopy training during COVID-19: the USA perspective
16:35
Biliary drainage for malignant hilar obstruction: ERCP, EUS, or PTBD?
17:00
The future role of AI In endoscopy
17:25
The current status in Bariatric Endoscopy
Future of GI disease
Lecture Theatre 1A
17:40-18:40
17:40
Risk stratification in UGIB: machine modeling vs clinical prediction
18:00
Role of AI in colonoscopy – quality assurance and polyp detection
18:20
FMT: ready for clinical application?
State Key Lab Meeting (2): Metabolism in GI cancer-molecular to clinic
Lecture Theatre 1B
17:40-18:40
17:40
Metabolic syndrome and colorectal cancer
18:00
m6A mediated glycolysis in colorectal cancer
18:20
SLC25A22 in Kras-mutant colorectal cancer